×
Cronos Group Total Liabilities 2017-2025 | CRON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cronos Group total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Cronos Group Total Liabilities 2017-2025 | CRON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cronos Group total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$71.7B
Zoetis (ZTS)
$69.5B
Daiichi Sankyo, - (DSNKY)
$49.8B
Takeda Pharmaceutical (TAK)
$49.3B
BeOne Medicines - (ONC)
$33.9B
Sandoz Group AG (SDZNY)
$26.7B
Summit Therapeutics (SMMT)
$19.2B
Merck (MKKGY)
$16.8B
Shionogi (SGIOY)
$15.2B
United Therapeutics (UTHR)
$13.8B
Neurocrine Biosciences (NBIX)
$13.2B
Orion OYJ (ORINY)
$11.2B
IPSEN (IPSEY)
$11.2B
Eisai (ESAIY)
$9.3B
Madrigal Pharmaceuticals (MDGL)
$8.7B
Corcept Therapeutics (CORT)
$7.4B
Grifols, S.A (GRFS)
$7B
Stevanato Group S.p.A (STVN)
$6.9B
Ionis Pharmaceuticals (IONS)
$6.8B
Hikma Pharmaceuticals Plc (HKMPF)
$5.4B
Ono Pharmaceutical (OPHLF)
$5.4B
Soleno Therapeutics (SLNO)
$3.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$3B
Crinetics Pharmaceuticals (CRNX)
$2.7B
NewAmsterdam Pharma (NAMS)
$2.7B
Hypermarcas (HYPMY)
$2.7B
Catalyst Pharmaceuticals (CPRX)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.3B
Ocular Therapeutix (OCUL)
$2.1B
Endo (NDOI)
$1.8B